Literature DB >> 22938712

Biosynthetic pathway to neuromelanin and its aging process.

Kazumasa Wakamatsu1, Takaya Murase, Fabio A Zucca, Luigi Zecca, Shosuke Ito.   

Abstract

Using model compounds of the melanic component of neuromelanin (NM) prepared by tyrosinase oxidation at various ratios of dopamine (DA) and cysteine (Cys) under physiological conditions, we examined a biosynthetic pathway to NM and its aging process by following the time course of oxidation to NM and the subsequent structural modification of NM under various heating conditions. Chemical degradation methods were applied to the synthetic NM. 4-Amino-3-hydroxyphenylethylamine (4-AHPEA) and thiazole-2,4,5-tricarboxylic acid (TTCA) were used as markers of benzothiazine and benzothiazole units, respectively. By following the time course of the biosynthetic pathway of synthetic NM, we found that neurotoxic molecules are trapped in NM. An aging simulation of synthetic NM showed that benzothiazine units in NM are gradually converted to benzothiazole during the aging process. Thus, natural NM was found to be similar to aged (heated) NM prepared from a 2:1 molar ratio of DA and Cys.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22938712     DOI: 10.1111/pcmr.12014

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  11 in total

Review 1.  Neuromelanin of the human substantia nigra: an update.

Authors:  Fabio A Zucca; Emy Basso; Francesca A Cupaioli; Emanuele Ferrari; David Sulzer; Luigi Casella; Luigi Zecca
Journal:  Neurotox Res       Date:  2013-10-24       Impact factor: 3.911

2.  Neuromelanin Modulates Heterocyclic Aromatic Amine-Induced Dopaminergic Neurotoxicity.

Authors:  Vivek Lawana; Se Young Um; Jean-Christophe Rochet; Robert J Turesky; Jonathan H Shannahan; Jason R Cannon
Journal:  Toxicol Sci       Date:  2020-01-01       Impact factor: 4.849

Review 3.  Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease.

Authors:  Fabio A Zucca; Juan Segura-Aguilar; Emanuele Ferrari; Patricia Muñoz; Irmgard Paris; David Sulzer; Tadeusz Sarna; Luigi Casella; Luigi Zecca
Journal:  Prog Neurobiol       Date:  2015-10-09       Impact factor: 11.685

Review 4.  Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease.

Authors:  Shengli Xu; Piu Chan
Journal:  Biomolecules       Date:  2015-06-05

Review 5.  Cellular and Molecular Aspects of the β-N-Methylamino-l-alanine (BMAA) Mode of Action within the Neurodegenerative Pathway: Facts and Controversy.

Authors:  Nicolas Delcourt; Thomas Claudepierre; Thomas Maignien; Nathalie Arnich; César Mattei
Journal:  Toxins (Basel)       Date:  2017-12-22       Impact factor: 4.546

6.  Density Functional Theory-Based Calculation Shed New Light on the Bizarre Addition of Cysteine Thiol to Dopaquinone.

Authors:  Ryo Kishida; Shosuke Ito; Manickam Sugumaran; Ryan Lacdao Arevalo; Hiroshi Nakanishi; Hideaki Kasai
Journal:  Int J Mol Sci       Date:  2021-01-29       Impact factor: 5.923

7.  The Metabolic Fate of ortho-Quinones Derived from Catecholamine Metabolites.

Authors:  Shosuke Ito; Yuta Yamanaka; Makoto Ojika; Kazumasa Wakamatsu
Journal:  Int J Mol Sci       Date:  2016-01-27       Impact factor: 5.923

8.  Norepinephrine and its metabolites are involved in the synthesis of neuromelanin derived from the locus coeruleus.

Authors:  Kazumasa Wakamatsu; Keisuke Tabuchi; Makoto Ojika; Fabio A Zucca; Luigi Zecca; Shosuke Ito
Journal:  J Neurochem       Date:  2015-09-04       Impact factor: 5.372

Review 9.  Oxidative Stress and Neuroinflammation Potentiate Each Other to Promote Progression of Dopamine Neurodegeneration.

Authors:  Jingyi He; Guofu Zhu; Guoqing Wang; Feng Zhang
Journal:  Oxid Med Cell Longev       Date:  2020-07-03       Impact factor: 7.310

10.  The Pro-Oxidant Activity of Pheomelanin is Significantly Enhanced by UVA Irradiation: Benzothiazole Moieties Are More Reactive than Benzothiazine Moieties.

Authors:  Hitomi Tanaka; Yui Yamashita; Kana Umezawa; Tomohisa Hirobe; Shosuke Ito; Kazumasa Wakamatsu
Journal:  Int J Mol Sci       Date:  2018-09-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.